209 related articles for article (PubMed ID: 32618393)
1. Atypical fibroxanthoma: An analysis of 105 tumors.
Bitel A; Schönlebe J; Krönert C; Wollina U
Dermatol Ther; 2020 Nov; 33(6):e13962. PubMed ID: 32618393
[TBL] [Abstract][Full Text] [Related]
2. Conception and Management of a Poorly Understood Spectrum of Dermatologic Neoplasms: Atypical Fibroxanthoma, Pleomorphic Dermal Sarcoma, and Undifferentiated Pleomorphic Sarcoma.
Soleymani T; Tyler Hollmig S
Curr Treat Options Oncol; 2017 Aug; 18(8):50. PubMed ID: 28762020
[TBL] [Abstract][Full Text] [Related]
3. S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS).
Helbig D; Ziemer M; Dippel E; Erdmann M; Hillen U; Leiter U; Mentzel T; Osterhoff G; Ugurel S; Utikal J; von Bubnoff D; Weishaupt C; Grabbe S
J Dtsch Dermatol Ges; 2022 Feb; 20(2):235-243. PubMed ID: 35099104
[TBL] [Abstract][Full Text] [Related]
4. Increase of atypical fibroxanthoma and pleomorphic dermal sarcoma: a retrospective analysis of four German skin cancer centers.
Kuntz T; Siebdrath J; Hofmann SC; Baltaci M; Schaller J; Hellmich M; von Goltzheim LS; Assaf C; Oellig F; Michalowitz AL; Helbig D; Kreuter A
J Dtsch Dermatol Ges; 2022 Dec; 20(12):1581-1588. PubMed ID: 36442137
[TBL] [Abstract][Full Text] [Related]
5. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
[TBL] [Abstract][Full Text] [Related]
6. Atypical Fibroxanthoma.
Chapman LW; Yu SS; Arron ST
Semin Cutan Med Surg; 2019 Mar; 38(1):E65-E66. PubMed ID: 31051027
[TBL] [Abstract][Full Text] [Related]
7. Atypical fibroxanthoma and pleomorphic dermal sarcoma: Is superficial infiltration in subcutaneous tissue acceptable in AFX?
van Midden D; Flucke UE; Amir AL; Bonenkamp JJ; Lubeek SFK; Blokx WAM
Ann Diagn Pathol; 2022 Jun; 58():151915. PubMed ID: 35276548
[TBL] [Abstract][Full Text] [Related]
8. Atypical fibroxanthoma and pleomorphic dermal sarcoma: Local recurrence and metastasis in a nationwide population-based cohort of 1118 patients.
Ørholt M; Abebe K; Rasmussen LE; Aaberg FL; Lindskov LJ; Schmidt G; Wagenblast AL; Petersen MM; Loya AC; Daugaard S; Herly M; Jensen DH; Vester-Glowinski P
J Am Acad Dermatol; 2023 Dec; 89(6):1177-1184. PubMed ID: 37634740
[TBL] [Abstract][Full Text] [Related]
9. Atypical fibroxanthoma: new insights.
Hussein MR
Expert Rev Anticancer Ther; 2014 Sep; 14(9):1075-88. PubMed ID: 24958232
[TBL] [Abstract][Full Text] [Related]
10. Atypical fibroxanthoma and pleomorphic dermal sarcoma: A reappraisal.
Cesinaro AM; Gallo G; Tramontozzi S; Migaldi M
J Cutan Pathol; 2021 Feb; 48(2):207-210. PubMed ID: 32583897
[TBL] [Abstract][Full Text] [Related]
11. Pleomorphic dermal sarcoma in a man with HIV: report with next-generation sequencing analysis and review of the atypical fibroxanthoma/pleomorphic dermal sarcoma spectrum.
Chen SX; Eichenfield DZ; Orme C; Hinds B
Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045146
[TBL] [Abstract][Full Text] [Related]
12. Pleomorphic Dermal Sarcoma.
Saleh JS; Whittington CP; Bresler SC; Patel RM
Surg Pathol Clin; 2024 Mar; 17(1):153-158. PubMed ID: 38278604
[TBL] [Abstract][Full Text] [Related]
13. Oncological Safety and Recurrence in the Surgical Treatment of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma of the Scalp.
Zeller J; Kiefer J; Braig D; Winninger O; Kraus D; Hagelstein S; Eisenhardt SU
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740535
[TBL] [Abstract][Full Text] [Related]
14. Pleomorphic Dermal Sarcoma: A Clinical and Histopathologic Emulator of Atypical Fibroxanthoma, but Different Biologic Behavior.
Carletti M; Nguyen DA; Malouf P; Ingersoll Z; Hosler GA; Weis SE
HCA Healthc J Med; 2022; 3(5):299-304. PubMed ID: 37425251
[TBL] [Abstract][Full Text] [Related]
15. Sarcoma-like tumor of head and neck skin.
Nonaka D; Bishop PW
Am J Surg Pathol; 2014 Jul; 38(7):956-65. PubMed ID: 24705313
[TBL] [Abstract][Full Text] [Related]
16. Incidence rate and clinicopathological features of 62 atypical fibroxanthomas in a North-Western Spanish population.
Iglesias-Pena N; López-Solache L; Martínez-Campayo N; Meilán-Sánchez I; Yebra-Pimentel MT; Balboa-Barreiro V; Paradela S; Fonseca E
Australas J Dermatol; 2020 Feb; 61(1):e22-e27. PubMed ID: 31264202
[TBL] [Abstract][Full Text] [Related]
17. Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: Updates on Classification and Management.
Soleymani T; Aasi SZ; Novoa R; Hollmig ST
Dermatol Clin; 2019 Jul; 37(3):253-259. PubMed ID: 31084719
[TBL] [Abstract][Full Text] [Related]
18. Surgical excision margins for fibrohistiocytic tumors, including atypical fibroxanthoma and undifferentiated pleomorphic sarcoma: A probability model based on a systematic review.
Jibbe A; Worley B; Miller CH; Alam M
J Am Acad Dermatol; 2022 Oct; 87(4):833-840. PubMed ID: 34587553
[TBL] [Abstract][Full Text] [Related]
19. The many faces of Atypical fibroxanthoma.
Agaimy A
Semin Diagn Pathol; 2023 Jul; 40(4):306-312. PubMed ID: 37438163
[TBL] [Abstract][Full Text] [Related]
20. Atypical fibroxanthoma/pleomorphic dermal sarcoma of the scalp with aberrant expression of HMB-45: a pitfall in dermatopathology.
Piras V; Ferreli C; Atzori L; Pinna G; Pilloni L
Pathologica; 2020 Jun; 112(2):105-109. PubMed ID: 32760054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
